Clinical trial
Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and…
NCT00102479 · Otsuka Pharmaceutical Development & Commercialization, Inc., Industry · Completed
Key facts
| NCT number | NCT00102479 |
|---|---|
| Title | Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents |
| Official title | A Phase II Study to Test PK Tolerability in Children and Adolescents |
| Lead sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia, Mania |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Start date | Jul 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Jan 31, 2005 |
| Last update posted | Apr 17, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: